Abstract
Glycosaminoglycans (GAGs) are a class of long linear anionic periodic polysaccharides. Their biological activities are very broad including tissue remodeling, regulation of cell proliferation, cell migration, cell differentiation, participation in bacterial/viral infections, and immune response. They can interact with many important biomolecular partners in the extracellular matrix of the cell including small drug molecules. Recently, several GAG-bioactive small molecule complexes have been experimentally and theoretically studied. Some of these compounds in complexes with GAGs may potentially interfere with protein–GAG or peptide–GAG multimolecular systems affecting the processes of cellular differentiation or have anti-inflammatory, antiviral as well as antithrombotic effects. Although many studies have been conducted on GAG–drug complexes, the molecular mechanisms of the formation of such complexes are still poorly understood. At the same time, the complexity of their physicochemical properties renders the use of both experimental and computational methods to study these molecular systems challenging. Here, we present the molecular dynamics-based protocols successfully employed to in silico analyze GAG–small molecule interactions.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Varki A, Cummings RD, Esko JD, Stanley P, Hart GW, Aebi M, Darvill AG, Kinoshita T, Packer NH, Prestegard JH, Schnaar RL, Seeberger PH, editors. (2015–2017) Essentials of glycobiology [Internet], 3rd edn. Cold Spring Harbor Laboratory Press, Cold Spring Harbor
Zsila F, Samsonov SA (2018) Molecular interactions of the anticancer agent ellipticine with glycosaminoglycans by in silico analysis. Carbohydr Res 462:28–33
Samsonov SA, Freza S, Zsila F (2019) In silico analysis of heparin and chondroitin sulfate binding mechanisms of the antiprotozoal drug berenil and pentamidine. Carbohydr Res 482:107742
Zsila F, Samsonov SA, Maszota-Zieleniak M (2020) Mind your dye: the amyloid sensor Thioflavin T interacts with sulfated Glycosaminoglycans used to induce cross-β-sheet motifs. J Phys Chem B 124(51):11625–11633
Maszota-Zieleniak M, Zsila F, Samsonov SA (2021) Computational insights into heparin-small molecule interactions: evaluation of the balance between stacking and non-stacking binding modes. Carbohydr Res 507:108390
Maszota-Zieleniak M, Zsila F, Samsonov SA (2022) Molecular dynamics approaches dissect molecular mechanisms underlying methylene blue–glycosaminoglycan interactions. Molecules 27(9):2654
Varki A (2017) Biological roles of glycans. Glycobiology 27(1):3–49
Vallet SD, Clerc O, Ricard-Blum S (2021) Glycosaminoglycan–protein interactions: the first draft of the glycosaminoglycan Interactome. J Histochem Cytochem 69(2):93–104
Künze G, Huster D, Samsonov SA (2021) Investigation of the structure of regulatory proteins interacting with glycosaminoglycans by combining NMR spectroscopy and molecular modeling–the beginning of a wonderful friendship. Biol Chem 402(11):1337–1355
da Silva PHR, Borges BC, Uehara IA, Soldi LR, de Araújo RA, Silva MJB (2021) Chemokines and the extracellular matrix: set of targets for tumor development and treatment. Cytokine 144:155548
Tracy LE, Minasian RA, Caterson EJ (2016) Extracellular matrix and dermal fibroblast function in the healing wound. Adv Wound Care 5(3):119–136
Smock RG, Meijers R (2018) Roles of glycosaminoglycans as regulators of ligand/receptor complexes. Royal Society Open Biol 8(10):180026
Bauer S, Zhang F, Linhardt RJ (2021) Implications of glycosaminoglycans on viral zoonotic diseases. Diseases 9(4):85
Almer J, Gesslbauer B, Kungl AJ (2018) Therapeutic strategies to target microbial protein--glycosaminoglycan interactions. Biochem Soc Trans 46(6):1505–1515
Crijns H, Vanheule V, Proost P (2020) Targeting chemokine—glycosaminoglycan interactions to inhibit inflammation. Front Immunol 11:483
Clerc O, Mariethoz J, Rivet A, Lisacek F, Pérez S, Ricard-Blum S (2019) A pipeline to translate glycosaminoglycan sequences into 3D models. Application to the exploration of glycosaminoglycan conformational space. Glycobiology 29(1):36–44
Scharnweber D, Hübner L, Rother S, Hempel U, Anderegg U, Samsonov SA, Hintze V et al (2015) Glycosaminoglycan derivatives: promising candidates for the design of functional biomaterials. J Mater Sci Mater Med 26(9):232
Stanley FE, Warner AM, Gutierrez SM, Stalcup AM (2009) Heparin-induced circular dichroism of chloroquine. Biochem Biophys Res Commun 388(1):28–30
Zsila F, Gedeon G (2006) Binding of anti-prion agents to glycosaminoglycans: evidence from electronic absorption and circular dichroism spectroscopy. Biochem Biophys Res Commun 346(4):1267–1274
Zsila F (2015) Glycosaminoglycans are potential pharmacological targets for classic DNA minor groove binder drugs berenil and pentamidine. Phys Chem Chem Phys 17(38):24560–24565
Zsila F, Juhász T, Kohut G, Beke-Somfai T (2018) Heparin and heparan sulfate binding of the antiparasitic drug imidocarb: circular dichroism spectroscopy, isothermal titration calorimetry, and computational studies. J Phys Chem B 122(6):1781–1791
Zsila F (2016) The anticancer agent ellipticine binds to glycosaminoglycans at mildly acidic pH characteristic of the extracellular matrix of tumor tissues. RSC Adv 6(1):810–814
Zsila F (2015) Glycosaminoglycan and DNA binding induced intra‐and intermolecular Exciton coupling of the bis‐4‐Aminoquinoline Surfen. Chirality 27(9):605–612
Gandhi NS, Mancera RL (2008) The structure of glycosaminoglycans and their interactions with proteins. Chem Biol Drug Des 72(6):455–482
Huang ML, Michalak AL, Fisher CJ, Christy M, Smith RA, Godula K (2018) Small molecule antagonist of cell surface glycosaminoglycans restricts mouse embryonic stem cells in a pluripotent state. Stem Cells 36(1):45–54
Egorova A, Bogner E, Novoselova E, Zorn KM, Ekins S, Makarov V (2021) Dispirotripiperazine-core compounds, their biological activity with a focus on broad antiviral property, and perspectives in drug design (mini-review). Eur J Med Chem 211:113014
Juhas S, Harris N, Il’kova G, Rehák P, Zsila F, Yurgenzon Kogan F, Koppel J et al (2018) RX-207, a small molecule inhibitor of protein interaction with glycosaminoglycans (SMIGs), reduces experimentally induced inflammation and increases survival rate in cecal ligation and puncture (CLP)-induced sepsis. Inflammation 41(1):307–314
Chazeirat T, Denamur S, Bojarski KK, Andrault PM, Sizaret D, Zhang F, Lecaille F et al (2021) The abnormal accumulation of heparan sulfate in patients with mucopolysaccharidosis prevents the elastolytic activity of cathepsin V. Carbohydr Polym 253:117261
Ansell J, Laulicht BE, Bakhru SH, Burnett A, Jiang X, Chen L, Steiner S et al (2021) Ciraparantag, an anticoagulant reversal drug: mechanism of action, pharmacokinetics, and reversal of anticoagulants. Blood 137(1):115–125
Almond A (2018) Multiscale modeling of glycosaminoglycan structure and dynamics: current methods and challenges. Curr Opin Struct Biol 50:58–64
Case DA, Ben-Shalom IY, Brozell SR, Kollman PA et al (2016) AMBER 2016. University of California, San Francisco
Kirschner KN, Yongye AB, Tschampel SM, González-Outeiriño J, Daniels CR, Foley BL, Woods RJ (2008) GLYCAM06: a generalizable biomolecular force field. carbohydrates. J Comput Chem 29:622–655
Wang J, Wolf RM, Caldwell JW, Kollman PA, Case DA (2004) Development and testing of a general AMBER force field. J Comput Chem 25:1157–1174
wwPDB, Consortium (2019) Protein Data Bank: the single global archive for 3D macromolecular structure data. Nucleic Acids Res 47(D1):520–528
Tripos L (2007) Tripos Mol2 file format. Tripos, St. Louis
Jorgensen WL, Chandrasekhar J, Madura JD, Impey RW, Klein ML (1983) Comparison of simple potential functions for simulating liquid water. J Chem Phys 79(2):926–935
Wang J, Wang W, Kollman PA, Case DA (2006) Automatic atom type and bond type perception in molecular mechanical calculations. J Mol Graph Model 25:247260
Nguyen H, Roe DR, Simmerling C (2013) Improved generalized born solvent model parameters for protein simulations. J Chem Theory Comput 9(4):2020–2034
Schrodinger (2010) LLC, The PyMOL Molecular Graphics System. LLC, PyMOL Mol. Graph. Syst. Version 1.3r1
Humphrey W, Dalke A, Schulten K (1996) VMD: Visual molecular dynamics. J Mol Graph 14:33–38
Massova I, Kollman PA (2000) Combined molecular mechanical and continuum solvent approach (MM- PBSA/GBSA) to predict ligand binding. Perspect Drug Discov Des 234(3):779–815
Aqvist J, Marelius J (2012) The linear interaction energy method for predicting ligand binding free energies. Comb Chem High Throughput Screen 4(8):613–626
Acknowledgments
This research was funded by the National Science Centre of Poland, grant number UMO-2018/30/E/ST4/00037.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2024 The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Maszota-Zieleniak, M., Samsonov, S.A. (2024). Molecular Dynamics Simulation-Based Prediction of Glycosaminoglycan Interactions with Drug Molecules. In: Gore, M., Jagtap, U.B. (eds) Computational Drug Discovery and Design. Methods in Molecular Biology, vol 2714. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-3441-7_8
Download citation
DOI: https://doi.org/10.1007/978-1-0716-3441-7_8
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-3440-0
Online ISBN: 978-1-0716-3441-7
eBook Packages: Springer Protocols